in rheumatoid arthritis. The concentrations of five normally occurring protease inhibitors in serum and synovial fluid were compared in patients with rheumatoid arthritis, osteoarthrosis, and normal controls. The patients with rheumatoid arthritis showed a significant rise in alpha1-antitrypsin, alpha1-antichymotrypsin, and inter-alpha-trypsin inhibitor (in decreasing order) in serum as well as in synovial fluid. In synovial fluid the inhibitors were present in their native form and bound to hyaluronate. A large molecular protein with immunological specificity of alpha1-antitrypsin, presumably a complex of alpha1-antitrypsin and a protease, could be shown in synovial fluid of all patients with classical and probable rheumatoid arthritis and not in that of the other subjects studied.
During the past decade it has been possible to sub-tissue damage in affected joints. Therefore, we invesdivide the antiproteolytic activity of human serum tigated the concentrations of several protease inhibiinto several individual inhibitors with different speci-tors in serum and in synovial fluids of patients with ficities (Heimburger, Haupt, and Schwick, 1971) . rheumatoid arthritis and compared them with findSome of these inhibitors belong to the group of acute ings in patients with osteoarthrosis. phase proteins like alpha1-antitrypsin and alpha2-macroglobulin. They are part of a control mechanism Materials apd methods of fibrinolysis, coagulation, and the kinin and com-The synovial fluid ofpatients was obtained by arthrocenteplement system. It is well known that these systems sis and immediately centrifuged at +4°C for 15 min at can release biologically active peptides that have 3000 r.p.m.; the supernate was frozen at -20°C and stored potent effects on blood vessels and on the activity of until used. Blood samples were taken from the anticubital leucocytes.
vein and the serum was also stored at -20°C. Normal synoThe importance of serum proteinase inhibitors is vial fluid was obtained at autopsyfrom the kneejoints from shown by the fact that inborn deficiencies lead to four subjects withoutjoint disease and serum was obtained characteristic diseases. Hereditary deficiency of from heart blood. These individuals had died from various alpha1-antitrypsin is associated with chronic obstruc-causes; they had not been dead for more than 6 hours betive pulmonary disease (Eriksson 1965 * Laurell and fore samples were taken. The following patients were intivekpulon1963ary diseasre (iksson, 1965; vestigated: eighteen (10 males and 8 females) with definite Eriksson, 1963) and severe infantile cirrhosis (Sharp, or classical rheumatoid arthritis and six (3 males and 3 Bridges, Krivit, and Freier, 1969) , while hereditary females) with probable rheumatoid arthritis according to angioneurotic oedema is caused by low concentration the criteria of the American Rheumatism Association or functional deficiency of complement esterase in- (Ropes, Bennett, Cobb, Jacox, and Jessar, 1958) . Eleven hibitor (C1INH) (Donaldson and Evans, 1963;  Scheidegger (1955) . The double-diffusion experiments were performed according to Ouchterlony (1949) . Gel chromatography of synovial fluid was done as follows. A 4 ml sample of synovial fluid from a patient with rheumatoid arthritis was incubated with hyaluronidase (100 IU/ml synovial fluid) for 15 min at 37°C. Then it was applied to a Sephadex G 200 column 2 5 x 95 cm. The eluting buffer was 0-1 mol/l Tris-HCl, 0-1 mol/l NaCl pH 7-6; 3 ml fractions were collected and concentrated fourfold by ultrafiltration.
Results
Some clinical findings that indicate the degree of local and systemic inflammation are listed in the Table. To obtain better information about the severity of synovial inflammation, the ratio of synovial fluid concentration to serum concentration (SF/S) and the molecular weights of the 5 proteinase inhibitors of each group of patients studied was plotted logarithmically X according to Kushner and Somerville (1971) (Fig. 1) . It is known that the concentration of a given synovial protein relative to its serum concentration reflects quite accurately the degree of synovial permeability and inflammation in the absence of local production or consumption. The resulting regression lines were compared to that of the four control (autopsied) subjects without joint disease (Fig. 1) . It can be seen that with an increasing degree of synovial inflammation the slope becomes less steep, reflecting proportionately greater permeability to large molecules. There was a significant difference of the levels in serum and synovial fluid for alpha1-antitrypsin, inter-alphatrypsin inhibitor, and alpha1-antichymotrypsin in patients with rheumatoid arthritis in comparison to patients with osteoarthrosis (Fig. 2) . In serum the difference was most pronounced for alpha1-antitrypsin (P < 0-01) followed by alpha1-antichymotrypsin (P <0-02), and inter-alpha-trypsin inhibitor (P < 0-05).
Immunoelectrophoresis of native synovial fluid showed the proteinase inhibitors in their characteristic position but always followed by a slower moving antigenically identical component (Fig. 3 Further experiments were designed to characterize this component. To exclude the possibility that it represents a complex of alpha1-antitrypsin and hyaluronidase, normal serum was incubated with the same concentration of hyaluronidase and submitted to immunoelectrophoresis using a specific antiserum. There was no change in mobility of alpha1-antitrypsin and no cathodally moving component appeared.
Gel chromatography of hyaluronidase-treated synovial fluid determined by electroimmunodiffusion revealed most of the alpha1-antitrypsin eluting in the third peak, but a definite maximum eluting between the first and second peak (Fig. 4) . When the material that eluted from the column in the first maximum was pooled, concentrated, and submitted to immunoelectrophoresis, it was apparent that it had the same electrophoretic mobility as the cathodally moving component in the synovial fluid after hyaluronidase treatment (Fig. 5) . We assume that the early eluting material represents a complex of alpha1-antitrypsin with another component, perhaps a protease. This complex is probably identical with the 'alpha1-antitrypsin of high molecular weight' detected by Ganrot (1967) in a number of normal and pathological human sera. The molecular weight of this complex was estimated by the method of Allison and Humphrey (1960) as approximately 200000. In a double diffusion experiment the complex showed antigenic identity with alpha1-antitrypsin.
Discussion
The presence of high concentrations of protease inhibitors in synovial fluid under various pathological conditions is of considerable interest. Because of the difficulty in obtaining normal synovial fluid, the number of controls was small (4 autopsy patients). But the differences between the pathological and the normal synovial fluids are very striking. Kushner and Somerville (1971) have shown that the presence of any serum protein in synovial fluid depends mostly on its Stokes radius. Molecules with a larger Stokes radius are present in lower concentrations than those with a smaller radius. With increasing permeability of the vascular walls and the interstitial hyaluronate during inflammation, this relationship changes: there is an absolute and relative increase in concentrations of proteins with high molecular weight. The highest -mL group.bmj.com on June 27, 2017 -Published by http://ard.bmj.com/ Downloaded from absolute increase we have seen in the concentration of alpha1-antitrypsin, alpha1-antichymotrypsin, and inter-alpha-trypsin inhibitor was in serum and synovial fluid of patients with rheumatoid arthritis. The concentrations of these proteins are also significantly higher in comparison to patients with osteoarthrosis. This finding is in agreement with the known fact that alpha1-antitrypsin and alpha1-antichymotrypsin (Aronsen, Ekelund, Kindmark and Laurell, 1972; Kueppers, 1968) belong to the group of acute phase proteins that respond to inflammatory stimuli with a substantial rise in concentration.
As Sandson and Hamerman (1964) have shown, the inter-alpha-trypsin inhibitor is present in high concentrations in synovial fluid and forms a complex with hyaluronate in patients withrheumatoid arthritis. From our observations this feature is not unique for the inter-alpha-trypsin inhibitor, but we have also seen complex formation of hyaluronate and the 4 other proteinase inhibitors tested (Fig. 3) . Alpha-1 antitrypsin differs from the other inhibitors by the fact that the native protein and the high molecular weight complex is bound to hyaluronate. The molecular weight as judged from the elution pattern from a Sephadex G 200 column and double diffusion (Allison and Humphrey, 1960 ) is approximately 200000. Some preliminary measurements of synovial fluid from patients with rheumatoid arthritis show a lower protease inhibiting activity than one might expect from the concentration of these inhibitors found immunologically (D. Brackertz and F. Kueppers, unpublished, 1973) . This finding could be explained by the inclusion of inactive inhibitor complexes in the immunological determinations.
It seems that the presence of protease inhibitors at the site of inflammation, first shown by Opie (Opie and Barker, 1907) , is important in limiting the destructive activity of proteases that are liberated from polymorphonuclear leucocytes and other necrotizing tissues. At least two such enzymes have been isolated and characterized (Janoff and Scherer, 1968; Lazarus, Daniels, Brown, Bladen, and Fullmer, 1968 
